Page results
-
The research aims to improve patient care and safety in acute and critical care, surgical care and perioperative care settings.
-
Achilles Therapeutics, a company built on research at UCLH, UCL Cancer Institute and the Francis Crick Institute has successfully raised $175.5 million through its initial public offering in the United States.
-
"Patient-initiated follow-up” appointments (PIFU ) allow you to arrange a follow-up appointment if and when you need it.
-
Information about your inpatient stay at University College London Hospitals NHS Foundation Trust.
-
Researchers at the NIHR UCLH Clinical Research Facility are the first in the world to start a new first-in-human trial investigating a novel treatment, called NVG-111, in patients with Non-Hodgkin lymphoma (NHL) subtypes.
-
The bites, stings, and animal-related injury service at the Hospital for Tropical Diseases offers high-quality, specialised treatment, care, and expert advice to adult patients who have experienced animal or plant-related injuries.
-
UCLH is delighted that His Majesty King Charles III has accepted the patronages of University College Hospital and the Royal London Hospital for Integrated Medicine.
-
A UCLH investment of £20 million will fund training for healthcare assistants and major new research facilities which will benefit patient care.
-
Prime Minister Boris Johnson came to the UCLH vaccination centre based at The Francis Crick Institute to receive his second COVID-19 vaccination.
-
Thrombotic Thrombocytopenia Purpura (TTP) is a rare disorder of the blood coagulation system.
